3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Epilepsy
1
Child Development Disorders, Pervasive
1
Autistic Disorder
1
Interventions
Sirolimus
4
LY3295668 erbumine
3
Everolimus
3
Anticonvulsants
2
perampanel
1
clevidipine
1
brivaracetam
1
Vigabatrin
1
Topotecan
1
Therapeutic Touch
1
Temozolomide
1
TAS-119
1
Sulfasalazine
1
Sevoflurane
1
Saline Solution
1
Radiotherapy
1
Propofol
1
Paclitaxel
1
Nitrous Oxide
1
Midazolam
1
Memantine
1
Medical Marijuana
1
Lidocaine
1
Levetiracetam
1
Ketamine
1
Immunoglobulins, Intravenous
1
Glycopyrrolate
1
Gabapentin
1
Fluid Therapy
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Epilepsy
×
Activator Appliances
×
Clear all
NCT03422367
2020-11-06
JETS
University of California, Los Angeles
Phase NA
Unknown
64 enrolled